Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics servic… [+1173 chars]Read More
Pharma giant Regeneron to buy 23andMe and its customers data for 256M TechCrunch
